Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Short term Debt (2016 - 2024)

Lifecore Biomedical, Inc. \De\ (LFCR) has 14 years of Short term Debt data on record, last reported at $773000.0 in Q4 2024.

  • For Q4 2024, Short term Debt changed 0.0% year-over-year to $773000.0; the TTM value through Nov 2024 reached $773000.0, changed 0.0%, while the annual FY2024 figure was $773000.0, 33.28% up from the prior year.
  • Short term Debt reached $773000.0 in Q4 2024 per LFCR's latest filing, roughly flat from $773000.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $98.6 million in Q3 2022 and bottomed at $580000.0 in Q2 2023.
  • Average Short term Debt over 5 years is $25.6 million, with a median of $11.7 million recorded in 2020.
  • Peak YoY movement for Short term Debt: skyrocketed 690.52% in 2020, then plummeted 99.22% in 2023.
  • A 5-year view of Short term Debt shows it stood at $11.2 million in 2020, then soared by 275.37% to $42.0 million in 2021, then rose by 14.29% to $48.0 million in 2022, then plummeted by 98.39% to $773000.0 in 2023, then changed by 0.0% to $773000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $773000.0 in Q4 2024, $773000.0 in Q3 2024, and $773000.0 in Q2 2024.